AI Portfolio Summary
In 2025 Q4, DAFNA Capital Management LLC maintained a portfolio of 87 distinct positions. They heavily accumulated shares in ATRICURE INC, increasing their position by 0.9%. Conversely, DAFNA Capital Management LLC completely exited their position in MERUS BV.
Total Positions
87
Quarter
2025 Q4
Top Holding
RVMD (11.2%)
Top 10 Concentration
54.9%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-25 of 87
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 11.18% | 7.58% |
#1
2
Prev: #3
|
4.5 | -52,662 | -8.0% |
P
S
|
604,514 | $48,149,540 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
XBI
SPDR S&P BIOTEC...
|
ETF | 9.53% | 9.94% |
#2
Prev: #2
|
3.9 | -65,000 | -16.2% |
P
S
|
336,505 | $41,030,055 | 2022 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
STXS
STEREOTAXIS INC
|
Healthcare | 7.31% | 10.51% |
#3
2
Prev: #1
|
2.9 | no change | no change |
P
S
|
13,680,554 | $31,465,274 | 2012 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ATRC
ATRICURE INC
|
Healthcare | 5.49% | 5.16% |
#4
1
Prev: #5
|
4.2 | 5,158 | 0.9% |
P
S
|
597,431 | $23,634,370 | 2012 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CYTK
CYTOKINETICS IN...
|
Healthcare | 5.48% | 5.36% |
#5
1
Prev: #4
|
2.2 | -23,943 | -6.1% |
P
S
|
370,997 | $23,573,149 | 2015 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IDYA
IDEAYA BIOSCIEN...
|
Healthcare | 4.07% | 3.63% |
#6
2
Prev: #8
|
1.6 | -33,183 | -6.1% |
P
S
|
506,740 | $17,518,002 | 2020 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AXGN
AXOGEN INC
|
Healthcare | 3.63% | 3.27% |
#7
2
Prev: #9
|
1.6 | -265,456 | -35.8% |
P
S
|
476,826 | $15,606,515 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
XENE
XENON PHARMACEU...
|
Healthcare | 3.00% | 2.86% |
#8
2
Prev: #10
|
1.2 | no change | no change |
P
S
|
287,939 | $12,905,426 | 2015 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IBB
ISHARES NASDAQ ...
|
ETF | 2.67% | 3.66% |
#9
2
Prev: #7
|
1.2 | -34,405 | -33.6% |
P
S
|
68,095 | $11,492,393 | 2006 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BHVN
BIOHAVEN LTD
|
Healthcare | 2.51% | 0.87% |
#10
18
Prev: #28
|
3.3 | 720,000 | 306.1% |
P
S
|
955,235 | $10,784,603 | 2018 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RCUS
ARCUS BIOSCIENC...
|
Healthcare | 2.39% | 2.11% |
#11
1
Prev: #12
|
1.0 | -196,297 | -31.3% |
P
S
|
431,329 | $10,278,570 | 2018 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NBIX
NEUROCRINE BIOS...
|
Healthcare | 2.33% | 2.45% |
#12
1
Prev: #11
|
0.9 | no change | no change |
P
S
|
70,615 | $10,015,325 | 2008 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DAWN
DAY ONE BIOPHAR...
|
Healthcare | 2.16% | 1.74% |
#13
1
Prev: #14
|
0.9 | no change | no change |
P
S
|
999,163 | $9,312,199 | 2023 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TNDM
TANDEM DIABETES...
|
Healthcare | 1.81% | 1.07% |
#14
9
Prev: #23
|
0.7 | no change | no change |
P
S
|
355,208 | $7,807,472 | 2015 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ASND
ASCENDIS PHARMA...
|
Healthcare | 1.40% | 1.63% |
#15
Prev: #15
|
0.6 | -5,000 | -15.1% |
P
S
|
28,177 | $6,008,463 | 2015 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DXCM
DEXCOM INC
|
Healthcare | 1.36% | 1.09% |
#16
6
Prev: #22
|
2.6 | 22,727 | 34.7% |
P
S
|
88,279 | $5,859,077 | 2012 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SNDX
SYNDAX PHARMACE...
|
Healthcare | 1.36% | 1.90% |
#17
4
Prev: #13
|
0.7 | -222,847 | -44.5% |
P
S
|
277,855 | $5,837,734 | 2020 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KALV
KALVISTA PHARMA...
|
Healthcare | 1.34% | 1.27% |
#18
1
Prev: #17
|
0.6 | -65,929 | -15.6% |
P
S
|
356,802 | $5,762,352 | 2018 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CMPS
COMPASS PATHWAY...
|
Healthcare | 1.30% | 1.15% |
#19
1
Prev: #20
|
0.5 | no change | no change |
P
S
|
811,046 | $5,596,217 | 2022 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
INGN
INOGEN INC
|
Healthcare | 1.29% | 1.22% |
#20
1
Prev: #19
|
2.6 | 221,446 | 36.6% |
P
S
|
827,071 | $5,557,917 | 2019 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
N/A
ASCENDIS PHARMA...
|
—
|
Bond/Debt | 1.27% | 1.34% |
#21
5
Prev: #16
|
0.5 | no change | no change |
P
S
|
4,000,000 | $5,460,000 | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
DNLI
DENALI THERAPEU...
|
Healthcare | 1.22% | 0.60% |
#22
16
Prev: #38
|
2.8 | 150,000 | 89.0% |
P
S
|
318,500 | $5,258,435 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MBX
MBX BIOSCIENCES...
|
Healthcare | 1.21% | 0.37% |
#23
29
Prev: #52
|
2.8 | 80,265 | 94.4% |
P
S
|
165,265 | $5,212,458 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BCAX
BICARA THERAPEU...
|
Healthcare | 1.02% | 1.24% |
#24
6
Prev: #18
|
0.5 | -55,418 | -17.5% |
P
S
|
261,583 | $4,402,442 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GLPG
GALAPAGOS NV
|
Healthcare | 0.99% | 1.11% |
#25
4
Prev: #21
|
0.4 | no change | no change |
P
S
|
130,175 | $4,256,723 | 2015 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MRUS
MERUS BV
|
Healthcare | 0.00% | 5.13% |
Sold All 😨
(Was: #6) |
0.3 | -220,451 | -100.0% |
CLOSED
|
— | $— | 2021 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SLNO
SOLENO THERAPEU...
|
Healthcare | 0.00% | 0.89% |
Sold All 😨
(Was: #27) |
0.3 | -53,000 | -100.0% |
CLOSED
|
— | $— | 2020 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CMPX
COMPASS THERAPE...
|
Healthcare | 0.00% | 0.82% |
Sold All 😨
(Was: #32) |
0.3 | -946,661 | -100.0% |
CLOSED
|
— | $— | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KRRO
KORRO BIO INC
|
Healthcare | 0.00% | 0.72% |
Sold All 😨
(Was: #36) |
0.3 | -60,804 | -100.0% |
CLOSED
|
— | $— | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KROS
KEROS THERAPEUT...
|
Healthcare | 0.00% | 0.32% |
Sold All 😨
(Was: #55) |
0.3 | -80,716 | -100.0% |
CLOSED
|
— | $— | 2022 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BDTX
BLACK DIAMOND T...
|
Healthcare | 0.00% | 0.29% |
Sold All 😨
(Was: #58) |
0.3 | -307,070 | -100.0% |
CLOSED
|
— | $— | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
URGN
UROGEN PHARMA L...
|
Healthcare | 0.00% | 0.14% |
Sold All 😨
(Was: #67) |
0.3 | -27,515 | -100.0% |
CLOSED
|
— | $— | 2018 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
STRO
SUTRO BIOPHARMA...
|
Healthcare | 0.00% | 0.09% |
Sold All 😨
(Was: #72) |
0.3 | -437,079 | -100.0% |
CLOSED
|
— | $— | 2018 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PHGE
BIOMX INC
|
Healthcare | 0.00% | 0.05% |
Sold All 😨
(Was: #74) |
0.3 | -401,136 | -100.0% |
CLOSED
|
— | $— | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
APRE
APREA THERAPEUT...
|
Healthcare | 0.00% | 0.05% |
Sold All 😨
(Was: #75) |
0.3 | -137,174 | -100.0% |
CLOSED
|
— | $— | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-25 of 87 holdings